SAINTE-FOY, QUEBEC--(MARKET WIRE)--Jun 21, 2007 -- Bioxel Pharma Inc. (CDNX:BIP.V - News), a leading manufacturer and supplier of taxane active pharmaceutical ingredients (API) and developer of targeted oncology drugs, is pleased to announce that the Corporation has submitted a Drug Master File (DMF) with the US Food & Drug Administration for its docetaxel drug.
